Related Experiment Video
Updated: Jul 10, 2026

10:00
Measurement of Lifespan in Drosophila melanogaster
Published on: January 7, 2013
Does age or life expectancy better predict health care expenditures?
1RAND, Santa Monica, CA 90401, USA. baoping_shang@rand.org
Health Economics
|October 16, 2007
Summary
Predicting healthcare spending is complex. This study found that remaining life expectancy, not just age, is a better predictor, suggesting longevity increases may be less costly than previously thought.
Area of Science:
- Health Economics
- Biostatistics
- Demography
Background:
- Determining factors for healthcare expenditure prediction remains a challenge.
- Existing models often struggle with the censoring of death, particularly concerning end-of-life spending.
Purpose of the Study:
- To compare the predictive power of chronological age versus predicted remaining life expectancy on healthcare expenditures.
- To account for both survivors and deceased individuals by using predicted life expectancy.
Main Methods:
- Hazard models were used to estimate life expectancy based on demographics and health.
- Regression analyses compared the predictive capabilities of age and life expectancy for healthcare costs.
- Predicted life expectancy was employed to overcome data censoring issues related to mortality.
Main Results:
- Life expectancy significantly outperforms age in predicting healthcare expenditures.
- The predictive power of life expectancy decreases when health status measures are included.
- Age offers minimal additional predictive value once life expectancy is considered.
Conclusions:
- Remaining life expectancy is a superior predictor of healthcare spending compared to chronological age.
- Models using life expectancy project lower future healthcare expenditures than age-based models.
- Increasing longevity may have a less substantial economic impact on healthcare costs than anticipated.
Related Concept Videos
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Life Tables
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Applications of Life Tables
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
